Clinical Trial Update: Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) Registry

View source ↗

Summary

This clinical trial update reports on the safety and effectiveness of BENLYSTA (belimumab) in a systemic lupus erythematosus registry, with results posted after…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• BENLYSTA (belimumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Systemic Lupus Erythematosus | Status: COMPLETED | Results posted: 2026-03-20